Project Grant R01CA294307
Award Date 8/13/25
Completion Date 7/31/30
Dollars Obligated $404K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- This $3,355,681 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) aims to evaluate the impact of accessible and scalable digital interventions to address co-occurring insomnia and depression in breast cancer survivors. The project will assess the efficacy of two evidence-based digital interventions, SHUTI and INTELLICARE, in treating these conditions both individually and through an adaptive approach that sequences the interventions based...
- This Project Grant award of $2,746,080, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), supports research on the effects of remotely-delivered cognitive behavioral stress management (R-CBSM) on cancer-accelerated aging in older, distressed breast cancer survivors. The project will enroll 192 breast cancer survivors within 3-12 months of completing initial treatment, some of whom received chemotherapy. Participants will undergo...
- This federal Project Grant award of $649,293 from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) aims to study healthcare utilization and outcomes across the cancer care continuum, with a focus on understanding the impact of social risk factors and screening among Latino patients. The 5-year project, awarded to Ochin, Inc., a nonprofit health IT collaborative in Oregon, will leverage a robust electronic health record database spanning over 2 million Latino...
- This NCI Early K99/R00 Project Grant from the National Cancer Institute's (NCI) Cancer Research Manpower (CFDA 93.398) program aims to refine and test the delivery of cognitive behavioral therapy for insomnia (CBT-I) to address insomnia and related symptoms in lung cancer survivors (LCS). The $224,968 award will fund a two-phase project. In the K99 phase, the grantee, Wake Forest University Health Sciences, will conduct stakeholder interviews and convene an advisory board to refine the CBT-I...
- This federal Project Grant award, totaling $696,140, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The grant aims to test a digital psychoeducation-activation tool and implementation strategy, called ICAN DEPCARE, to improve uptake of evidence-based depression treatment among cancer patients. The project, led by The Trustees of Columbia University in the City of New York, will conduct a clinic-level cluster randomized...
- The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh. The grant will fund a "Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES" to address clinically significant levels of depression, pain, and fatigue experienced by over 18 million Americans living with cancer. The project aims to...
- This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $599,339 to the University of Miami to conduct a randomized clinical trial evaluating the efficacy of a multidisciplinary group-based telehealth intervention (HORIZONS) for improving quality of life, psychological distress, symptom burden, coping, and self-efficacy in hematopoietic stem cell transplant survivors living with chronic graft-versus-host disease. The study aims to...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $402,401 to the University of Missouri System to conduct a pilot study on the feasibility and impact of a metacognitive strategy training (MCST) intervention for women with cancer-related cognitive impairment (CRCI) following breast cancer treatment. The study aims to examine the effects of MCST on cognitive performance, frontoparietal neural functioning, and functional...
- This $431,970 federal Project Grant awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) aims to develop a culturally-adapted, behavioral intervention called "South Asian Family Approaches to Disease (SAFAD)" to support self-management and alleviate stress, loneliness, and social isolation among South Asian breast cancer survivors and their family caregivers. The grant recipient, The Leland Stanford Junior University, will pursue two specific...
- The U.S. Department of Health and Human Services, National Institutes of Health (NIH) awarded a $406,080 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The purpose of this 5-year grant, awarded on April 1, 2025, is to develop and test a novel daily, digital mindfulness-based intervention to reduce depressive symptoms in post-treatment cancer patients. The project will first create the...